Table 2 Predictors of Crohn's disease and combined psychosomatic outcome measure in 87 CD patients within two years
From: High-utilizing Crohn's disease patients under psychosomatic therapy*
a) Univariate correlation | ||||
|---|---|---|---|---|
outcome of Crohn's disease (worse) | ||||
predictors (t0) | health care utilization | HRQL | clinical course | sum score |
CDAI | •145 | •040 | •470*** | •324* |
steroid intake | •291* | •025 | •352** | •306* |
disease duration | •129 | •226* | •01 | •059 |
sick leave at randomization | •288* | •021 | •315* | •354** |
depression (BDI) | .587*** | •306* | •384** | •248 |
anxiety (STAI) | •101 | •655*** | •255 | •349* |
behavior control (FK 2) | -•162 | -•230* | -•069 | -•043 |
b) Regression analysis | ||||
Health care utilization (HCU, high) | ||||
Model: r2 = 0.15 | F = 2.32 | p = 0.09 | ||
β | T | p | ||
1. Disease duration | 0.92 | 2.1 | 0.04 | |
Health-related quality of life (HRQL, low) | ||||
Model: r2 = 0.51 | F = 15.5 | p = 0.00001 | ||
β | T | p | ||
1. Anxiety (STAI) | -0.45 | -3.9 | 0.0003 | |
2. Behavior control (FK 2) | 0.22 | 2.0 | 0.05 | |
Clinical course of disease (CCD, worse) | ||||
Model: r2 = 0.28 | F = 6.16 | p = 0.006 | ||
β | T | p | ||
1. CDAI (t0) | -0.43 | -2.9 | 0.007 | |
HR sum score: (HCU, HRQL, CCD) | ||||
Model: r2 = 0.22 | F = 7.9 | p = 0.0009 | ||
β | T | p | ||
1. steroid intake | 0.31 | 2.6 | 0.01 | |
2. depression (BDI) | 0.30 | 2.5 | 0.02 | |